December 31, 1998

Henry Schein Buys Vaccine Supplier

Healthcare products direct marketer Henry Schein Inc., Melville, NY, announced Dec. 29 that it will acquire General Injectables and Vaccines for $65 million in cash and up to $80 million in additional sales incentives. The acquisition of GIV, Bastian, VA, is Schein's sixth of 1998 and fourth in the United States. The direct-to-physician supplier also has purchased Bedsole Medical Co., Mobile, AL, Columbia Medical, Columbia, MD, and Meer Dental Supply, Canton, MI, with combined annual revenues of $217 million. GIV's annual revenues for 1998 are an estimated $118 million. GIV will become part of Schein's Medical Group but will operate as a stand-alone company. It distributes vaccines to 32,000 medical office customers through a 50-person call center that handles more than 1 million calls per year. The acquisition expands Schein's position in the vaccine market, which CEO Stanley Bergman predicts will see annual growth of 15 percent for the next five years.
Similar Articles

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in Agency

From Information to Insight: Harnessing the Power of Big Data

Modern Family: A Reality for Today's Marketers

Modern Family: A Reality for Today's Marketers

Tide, Nordstrom, and Gap are three brands that market to the modern family

Rosetta Finds New CEO From Within

Rosetta Finds New CEO From Within

Publicis Groupe-owned digital agency Rosetta has appointed its former president and chief client officer Tom Adamski as CEO.